Caspase 9 inhibition and bri2 peptides for treating dementia

Inhibition de la caspase 9 et peptides bri2 dans le traitement de la démence


Methods are provided for treating dementia and or impaired cognition, as well as assays useful for identifying novel anti-dementia agents. Compounds and compositions for treating dementia and or impaired cognition are also provided.
La présente invention concerne des méthodes de traitement de la démence et/ou de la déficience cognitive, ainsi que des dosages utiles dans l'identification de nouveaux agents contre la démence. L'invention a également trait à des composés et à des compositions permettant de traiter la démence et/ou la déficience cognitive.




Download Full PDF Version (Non-Commercial Use)

Patent Citations (5)

    Publication numberPublication dateAssigneeTitle
    US-2009018094-A1January 15, 2009Loma Linda University Medical Center, George Mason University, Stony Brook University, The Regents Of The University Of CaliforniaInhibition of brain enzymes involved in cerebral amyloid angiopathy and macular degeneration
    US-2009099826-A1April 16, 2009Yigong ShiCaspase-9:bir3 domain of xiap complexes and methods of use
    US-2010221760-A1September 02, 2010Tae-Wan Kim, Hwang Jeremy CMETHODS AND COMPOSITIONS FOR DETECTING AND QUANTIFYING sAPPbeta
    US-2010256173-A1October 07, 2010Eckard WeberMethod of Treating Cognitive Impairment
    US-2010298202-A1November 25, 2010Mayo Foundation For Medical Education And ResearchBri polypeptides and reducing ab aggregation

NO-Patent Citations (0)


Cited By (0)

    Publication numberPublication dateAssigneeTitle